The frequently reported amino acid covariation of the highly polymorphic V3 region of the exterior envelope glycoprotein of human immunodeficiency virus type 1 (HIV-1) has been assumed to reflect functional interactions, or fitness epistasis, between residues. However, non-random association of amino acids, or linkage disequilibrium, has many possible causes, including population subdivision. If the amino acids at a set of sequence sites differ in frequencies between two subpopulations, then analysis of the whole population may reveal linkage disequilibrium even if it does not exist in both subpopulations. HIV-1 has a complex population structure, and the effects of this structure on linkage disequilibrium were investigated by estimating within-and among-subpopulation components of variance in linkage disequilibrium. The amino acid covariation previously reported is explained by differences in amino acid frequencies among virus populations in different patients and by nonsystematic 2 disequilibrium among patients. Disequilibrium within patients appears to be entirely due to differences in amino acid frequencies among sampling time points and among chemokine coreceptor usage phenotypes of virus particles, but not source tissues.
Introduction
Linkage disequilibrium refers to the non-random association of alleles among loci or the non-random association of residues among molecular sequence sites. The departure of alleles from random association is of considerable interest because it reflects important population genetic processes (reviewed by SLATKIN 2008) and may have important consequences for the efficiency of natural selection and the evolution exterior envelope glycoprotein, gp120, encoded by the env gene (BICKEL et al. 1996; GILBERT et al. 2005; KORBER et al. 1993; POON et al. 2007; TRAVERS et al. 2007) . V3 has been a focus of attention because it is the main determinant of which cell types are infected by HIV-1 (HWANG et al. 1991 ) and because it is the primary target for neutralizing antibodies (ZOLLA-PAZNER 2004) . The motivation for these studies has been the discovery of functional interactions among residues that may aid in vaccine development, thereby explicitly or implicitly assuming that the observed covariation is due to fitness epistasis. However, HIV-1 has a complex population structure, which may contribute to the observed linkage disequilibrium.
The basic population unit of HIV-1 is the virus population within a patient.
These populations are themselves structured geographically into major clades, called "subtypes", which are nested within "groups" (GAO et al. 1999) . Within patients, the virus population may be subdivided among host tissues and among foci of infection within host organs (e.g., FROST et al. 2001; WONG et al. 1997) . In addition, because of the rapid evolution of HIV-1, the viral population within a patient may also be structured temporally, with DNA sequences sampled at intervals of months or years often exhibiting significantly different site-specific frequencies (e.g., BONHOEFFER et al. 1995; SHANKARAPPA et al. 1999; WOLINSKY et al. 1996) .
The virus population within a patient may also be subdivided among host cell
types. An HIV-1 particle (virion) enters a cell through interactions between gp120 on the virion surface and two cell-surface receptors: the CD4 receptor and one of two chemokine coreceptors, either CCR5 or CXCR4 (reviewed by WYATT and SODROSKI 1998) . Binding to CD4 causes conformational changes to gp120 that expose V3 for coreceptor binding (HUANG et al. 2007; HUANG et al. 2005) . And since target cell types vary in their expression of chemokine coreceptors, macrophages expressing predominantly CCR5 and T cells expressing predominantly CXCR4, the coreceptor bound by V3 determines the type of cell infected. V3 determines which coreceptor is bound (DITTMAR et al. 1997; SPECK et al. 1997) through the amino acid composition of the crown, or tip, of the V3 structure (CORMIER and DRAGIC 2002) . Therefore, the virus population infecting a patient may be subdivided among host cell types based on the coreceptor usage phenotype imparted by V3.
Studies of V3 amino acid covariation have invariably used only one or a few sequences from each of many patients to deal with the statistical non-independence of multiple sequences from the same patient. Therefore, these studies have not been designed to rule out the possibility that the linkage disequilibrium observed is caused by population subdivision among and within patients. Some of these studies have also attempted to control for the lack of independence among the viral sequences from different patients due to phylogenetic relationships caused by transmission histories (POON et al. 2007; TRAVERS et al. 2007) . However, because the phylogenetic methods employed assume the independent evolution of sequence sites and do not take into account the substantial recombination in HIV-1 (LEVY et al. 2004 ) these approaches are unlikely to be valid. Here, I have investigated the effects of population subdivision on V3 amino acid covariation by estimating components of variance in linkage disequilibrium. I show that the majority of the disequilibrium observed at the global population level is due to differences in amino acid frequencies among patients. These differences among patients are, in turn, due mainly to differences in amino acid frequencies among time points and coreceptor usage phenotypes within patients. In addition, none of the disequilibrium appears to be associated with coreceptor usage phenotypes, indicating that fitness epistasis is not a cause of disequilibrium. These results caution against interpreting residue covariation or coevolution as evidence for fitness epistasis.
Methods
Sequence dataset: Analyses were restricted to HIV-1 subtype B, the most commonly sequenced subtype and the main subject of previous studies of V3 amino acid covariation. Sequences were downloaded from the HIV Sequence Database (www.hiv.lanl.gov). The criteria for inclusion were that the sequences (1) were from an identified patient in the database (with a "Patient ID"), (2) had the typical V3 length of 35 amino acids, (3) had Cysteines at both termini (these are absolutely conserved in functional V3), and (4) did not contain undetermined residues. A small minority of the resulting sequences (0.5%) could not be aligned with the remaining sequences without the addition of alignment gaps; these sequences were removed to avoid ambiguous alignments. On October 30, 2008, these criteria resulted in 35883 sequences from 3297 patients. For the purpose of comparison with previous studies, only one sequence per patient was used to identify linkage disequilibrium in the global population. Analyses of the effects of population subdivision among and within patients, which required at least 20 sequences per patient, involved 63 different patients. Sequences in the datasets analysed aligned unambiguously and did not require alignment gaps; this was confirmed by eye and by the automatic sequence alignment program MUSCLE (EDGAR 2004) .
Measuring and testing linkage disequilibrium: Linkage disequilibrium was measured in the usual manner, with the coefficient of linkage disequilibrium:
where p ij is the observed frequency of sequences containing the amino acids A i and B j at sites A and B (the haplotype or gametic frequency), and p i and p j are the observed frequencies of these amino acids at the individual sites (WEIR 1996) . D ij may be interpreted as the deviation of the haplotype frequency from its expected frequency under linkage equilibrium. The statistical significance of linkage disequilibrium at a pair of sequence sites was determined with a chi-square test for multiple alleles at each site:
where k and l are the numbers of amino acids at each site and n is the number of sequences (sample size) (WEIR 1996) . The degrees of freedom for this test are (k -1)(l -1). To control for inflation of the type 1 error rate, α, due to testing multiple pairs of polymorphic sites, the family-wise error rate, α/c, where c is the number of tests, was used as the level of significance (WEIR 1996) . Comparisons were made between all possible pairs of polymorphic V3 amino acid sites. Since the V3 sequences analysed are 35 amino acids long and the two terminal amino acid sites are absolutely conserved, there were a maximum of 33(32)/2 = 528 possible pairs of polymorphic sites. Tests were made even more conservative by using α = 0.001.
These tests are sensitive to alleles with low frequencies, producing spurious significant results (AWADALLA et al. 1999; WEIR and HILL 1986) . Therefore, tests were restricted to amino acids with a minimum frequency of 10%, as in Awadalla (1999) . Previous studies of V3 amino acid covariation have reported detecting unrealistically high numbers of significant covariations (BICKEL et al. 1996; KORBER et al. 1993) , possibly because of this effect. were estimated using the modified Nei-Gojobori method with the Jukes-Cantor model of nucleotide evolution and a nucleotide transition-to-transversion ratio of 2 (estimated using the Kimura-two-parameter model of nucleotide evolution). Standard errors (SE) of distances were estimated using 500 bootstrap samples of the data.
Distances were calculated between groups of sequences, such as between the sequences belonging to different chemokine coreceptor usage phenotypes. Statistical significance was determined using the Z-test. Analyses were carried out using the computer application MEGA 4.0 (TAMURA et al. 2007) . Phylogeny-based methods of testing for positive selection were not used because they are not appropriate for these data; the high rate of recombination in HIV-1 cannot be accommodated by phylogeny reconstruction methods and results in a high rate of false positives (LEMEY et al.
2006).

Results
Population subdivision among patients: V3 is highly polymorphic (Fig. 1 ). Using one sequence from each of the 3297 patients in the dataset, statistically significant linkage disequilibrium was detected for 10 pairs of sites that were also identified when analysing all sequences from 51 patients, each with a minimum of 100 sequences sampled (8600 sequences in total) ( Table 2) . Covariation between amino acids at these sites has been commonly reported (BICKEL et al. 1996; GILBERT et al. 2005; KORBER et al. 1993; POON et al. 2007; TRAVERS et al. 2007 ). These sites include three sites (11, 13, and 25) that are amongst the most polymorphic and that have been implicated in determining chemokine coreceptor usage (DE JONG et al. 1992; FOUCHIER et al. 1992; HUNG et al. 1999 ).
Using the 51-patients dataset, statistically significant linkage disequilibrium was detected for 48 pairs of sites. Linkage disequilibrium variance components were estimated for these data with the sequences from each patient identified as a separate subpopulation. Variance components for these site pairs show consistently
with mean D IS 2 (0.00438) nearly two orders of magnitude lower than mean D ST 2 (0.34336). This indicates that, for every pair of sites, the linkage disequilibrium detected for the whole population is due overwhelmingly to differences in sitespecific amino acid frequencies among the virus subpopulations infecting patients.
D´I S 2 > D´S T 2 consistently among pairs of sites as well, with mean D´I S 2 (0.34654) more than two orders of magnitude higher than mean D´S T 2 (0.00274) and equal to 99% of the mean total variance in linkage disequilibrium, D IT 2 (0.34928). This shows that the disequilibrium within patients is mainly nonsystematic among patients.
Nonsystematic disequilibrium is also evident from the lack of overlap among patients in site pairs with significant disequilibrium (data not shown). Table 2 shows variance components for the 10 site pairs with significant disequilibrium also detected when analysing the dataset consisting of one sequence from each of 3297 patients.
Therefore, the linkage disequilibrium observed for the entire subtype B population is explained by differences in amino acid frequencies among patients and nonsystematic disequilibrium among patients. However, nonsystematic disequilibrium among patients cannot automatically be attributed to genetic drift because patients are not identical environments (Table 1) . Patients differ in various aspects of their immune systems and in the tissue sources, sampling times (relative to initial infection) and chemokine coreceptor usage phenotypes of their sampled V3 sequences.
Nonsystematic linkage disequilibrium among patients could arise from further population subdivision within patients among tissues, sampling times and coreceptor usage phenotypes.
Population subdivision among source tissues within patients:
To test the effect of population subdivision among source tissues within patients, sequences from seven patients were analysed. Each of these patients had at least 30 sequences sampled from each of two distinct tissues (no patient had 30 sequences sampled from each of more than two distinct tissues). Three of these patients are from the 51-patient dataset used to test the effect of population subdivision among patients. Tissue sources labelled "blood", "plasma", "PBMC" (peripheral blood mononuclear cells), and "serum" in the HIV-1 Sequence Database were grouped into the single tissue category "blood".
And tissue sources labelled "semen", "seminal cells" and "seminal plasma" were grouped into the single category "semen". There is low total variance in linkage disequilibrium (D IT 2 ) in five out of the seven patients (Table 3 ). Each of these five patients had sequences sampled from blood and either semen or lymph node. For one of these patients, no site pairs exhibited statistically significant disequilibrium. This is consistent with the low variance within patients when patients were analysed as subpopulations in the 51-patients dataset (D IS 2 ; Table 2 ). The remaining two patients, which had samples taken from blood and cerebral spinal fluid, exhibited considerable total variance in disequilibrium, at levels similar to the total variance in the 51- Tables 3 and 2 (Table 5) , although the inequalities are not nearly as large as in the analysis of variance components among patients ( Table 2 ).
The inequalities were much larger for the patient with R5 and X4 sequences than for the other two patients, possibly because of the greater isolation between R5 and X4 phenotype subpopulations (R5 and R5X4 both use CCR5). Indeed, for the patient with R5 and X4 sequences, the within-phenotype variance component, D IS 2 , is 0 for the majority of 38 significant site pairs because one or both sites of a pair are fixed for a different amino acid in each phenotype subpopulation (data not shown). This result suggests that the linkage disequilibrium observed within patients harbouring more than one coreceptor usage phenotype is to some extent due to differences in amino acid frequencies among phenotypes, especially between R5 and X4. Tests for positive selection between phenotypes within patients show that d N is significantly greater than d S for the patient harbouring R5 and X4 phenotypes only ( Table 5 ), indicating that positive selection explains the differences in allele frequencies between these phenotypes.
The nonsystematic linkage disequilibrium observed among patients (Table 2) could arise if patients differ in the predominant coreceptor usage phenotype of their virus populations and if the disequilibrium within phenotypes is nonsystematic among phenotypes. However, there is only weak evidence for nonsystematic disequilibrium among phenotypes (D´I S 2 > D´S T 2 ; Table 5 ). The lack of strong evidence for nonsystematic disequilibrium among phenotypes suggests that disequilibrium is not correlated with V3 function, and therefore that fitness epistasis is an unlikely cause of linkage disequilibrium.
Population subdivision among patients within phenotypes:
If fitness epistasis were a major cause of linkage disequilibrium in V3, then most of the variance in disequilibrium for a coreceptor usage phenotype would be within, rather than among, patients harbouring that phenotype (D IS 2 > D ST 2 ). This would indicate that the disequilibrium is associated with the phenotype rather than differences in allele frequencies among patients. It would also be expected that the disequilibrium within patients would be systematic among patients for a given phenotype (D´I S 2 < D´S T 2 ). To test these predictions, the total variance in disequilibrium was estimated for individual phenotypes and partitioned among patients. Datasets were constructed for each phenotype for which at least two patients each had 30 or more sequences sampled.
These datasets could be constructed for the R5 and R5X4 phenotypes, but not the X4 phenotype. Thirteen patients were used in these analyses, all of which contained R5 sequences, and two of which also contained R5X4 sequences. Three of the patients are from the dataset used to test for an effect of phenotype within patients (Table 5) , and one is from the 51-patients dataset. These analyses show that for site pairs with statistically significant disequilibrium, D IS 2 < D ST 2 and D´I S 2 > D´S T 2 consistently for the R5 phenotype and nearly always for the R5X4 phenotype (Table 6 ). This is opposite to what would be expected if epistasis were causing most of the disequilibrium.
Values for the variance components are similar to those observed when partitioning the variance in the whole population among patients (Table 2) . Therefore, the disequilibrium observed within these phenotypes from data pooled across patients is mainly due to differences in amino acid frequencies among patients and nonsystematic disequilibrium among patients. In accordance with this result, comparisons among patients within each phenotype show virtually no overlap in the identities of site pairs with significant disequilibrium (data not shown). This result indicates that the linkage disequilibrium observed between V3 amino acid sites does not reflect functional interactions related to coreceptor usage, and is therefore unlikely to be caused by fitness epistasis.
Population subdivision among patients independent of within-patient subdivision:
The above analyses show that linkage disequilibrium within patients is at least partly attributable to population subdivision among sequences sampled in different years and among coreceptor usage phenotypes. To analyse the residual disequilibrium among and within patients after controlling for time and phenotype, variance components were estimated for sequences sampled in a single year from a single phenotype within individual patients. Only three patients had samples of at least 20 sequences from a single year and phenotype, and for all three patients the phenotype was R5. These three patients were also used in the previous analysis of population subdivision within and among patients within phenotypes (Table 6 ). For this dataset, 14 site pairs exhibit statistically significant disequilibrium (Table 7) . patients. This confirms that the disequilibrium for the whole population (the three patients) is largely due to differences in amino acid frequencies among the patients.
Note that the sequences from all three patients were from the same phenotype, and therefore the differences among patients cannot be attributed to differences in phenotype. However, the differences among these patients may be attributed to differences in time of sampling since initial infection and to differences in immune selection on V3. Although D´I S 2 > D´S T 2 for all site pairs, the inequalities are smaller than those observed for the 51-patients dataset, and no disequilibrium could be detected within individual patients, suggesting that this inequality is due to differences in amino acid frequencies among patients rather than nonsystematic disequilibrium among patients. This result shows that in the absence of population subdivision within patients the linkage disequilibrium observed for V3 sequences pooled from different patients is caused by differences in amino acid frequencies among patients and not by disequilibrium within patients. Therefore, this result confirms that the disequilibrium observed within patients in the earlier analyses of this study is the result of population subdivision within patients.
Discussion
The substantial linkage disequilibrium, or amino acid covariation, reported from analyses of one or a few V3 sequences from each of many patients (BICKEL et al. 1996; GILBERT et al. 2005; KORBER et al. 1993; POON et al. 2007; TRAVERS et al. 2007 ) can be explained by population subdivision among and within patients. Most of this disequilibrium is attributable to differences in amino acid frequencies among patients and among time points and coreceptor usage phenotypes within patients.
Within phenotypes, most of the variance in disequilibrium is explained by differences in amino acid frequencies among patients and nonsystematic disequilibrium among patients. This suggests that the disequilibrium is not associated with V3 function, and therefore is unlikely to be caused by fitness epistasis. The analysis of sequences from a single year and the same phenotype within each of several patients showed that the total variance in linkage disequilibrium is explained by differences in amino acid frequencies among patients, with no significant disequilibrium detected within these patients. This confirms the role of differences in amino acid frequencies among virus subpopulations infecting different patients in generating disequilibrium at the whole population level, and the role of within-patient population subdivision in generating disequilibrium within patients. Frost et al. (2001) report evidence of population subdivision among foci of infection within the spleen affecting the nucleotide diversity of the V1/V2 region of the HIV-1 env gene. Population subdivision at this small scale, within a tissue type, is in contrast to the finding in the present study that subdivision among source tissues does not contribute to the total variance in linkage disequilibrium. A possible explanation for this difference is that Frost et al. may have detected stochastic effects of subdivision (e.g., founder effects and genetic drift) on synonymous nucleotide differences among subpopulations, whereas, in the case of V3 amino acid disequilibrium, similar selection across tissues may overwhelm the stochastic effects of subdivision among tissues.
Genetic drift and other stochastic forces alone are unlikely explanations for the effects of population subdivision on linkage disequilibrium in V3 for several reasons.
First, genetic drift is not observed for V3 under severe serial population bottlenecks in culture, in contrast to other similar-sized HIV-1 protein regions (YUSTE et al. 2000) .
This is an important observation because HIV-1 appears to undergo a severe population bottleneck during inter-patient transmission (DERDEYN et al. 2004 ).
Second, shortly after initial infection, V3 quickly evolves toward the sequence with the most common amino acid at each site for the R5 phenotype (DA SILVA 2006; ZHANG et al. 1993) , indicating strong selection by CCR5. This is not surprising considering that V3 is the main determinant of which chemokine coreceptor is used by a virion (DITTMAR et al. 1997; SPECK et al. 1997 ) through amino acid variation in its crown (CORMIER and DRAGIC 2002) , and considering that V3 modulates the use of the coreceptor (DE JONG et al. 1992; HUNG et al. 1999) and thereby affects the ratelimiting step in cellular infection (PLATT et al. 2005 ). Third, a wide variety of comparative sequence analysis methods have been used to show that the V3 region is under strong positive selection (e.g., BONHOEFFER et al. 1995; DA SILVA 2006; GERRISH 2001; NIELSEN and YANG 1998; TEMPLETON et al. 2004; WILLIAMSON 2003; YAMAGUCHI and GOJOBORI 1997) . Evidence of strong selection on V3 is consistent with the observation in the present study of positive selection between time points and between coreceptor usage phenotypes within patients.
Fitness interactions, or fitness epistasis, among V3 amino acids could be reasonably hypothesized given that amino acids at several sites appear to be involved in determining coreceptor usage (DE JONG et al. 1992; FOUCHIER et al. 1992; HUNG et al. 1999; PASTORE et al. 2006) . Furthermore, structural analyses have suggested interactions between some V3 sites that may affect V3 structural conformation and thereby coreceptor usage (CARDOZO et al. 2007; GORRY et al. 2007; ROSEN et al. 2006) , although none of these interactions has been demonstrated through functional analyses or fitness assays. If fitness epistasis related to coreceptor tropism causes linkage disequilibrium in V3, the disequilibrium would be predicted to correlate with coreceptor usage phenotype. In other words, there should be significant disequilibrium within phenotypes and this disequilibrium should be nonsystematic among phenotypes. However, there is no disequilibrium within phenotypes, apart from that caused by differences in amino acid frequencies and nonsystematic disequilibrium among patients. Therefore, there is no evidence for fitness epistasis related to coreceptor usage causing linkage disequilibrium in V3.
However, there are two factors that may obscure an association between linkage disequilibrium and coreceptor usage phenotype. First, other gp120 regions, such as V1/V2 (e.g., PASTORE et al. 2006) , also affect coreceptor tropism. This may weaken any existing association between fitness epistasis among V3 residues and phenotype. Second, positive epistasis between beneficial mutations may cause the interacting residues to quickly spread to fixation within a phenotype subpopulation, thus eliminating polymorphism from the interacting sites. Such epistasis does not generate lasting linkage disequilibrium within a phenotype subpopulation and therefore may not result in an association between disequilibrium and phenotype.
Instead, such a scenario may produce variance in disequilibrium and nonsystematic disequilibrium among phenotypes due to differences in amino acid frequencies among phenotypes. However, the weak evidence for nonsystematic disequilibrium among phenotypes (Table 5) 
